APA

Fontein D. B. Y., Charehbili A., Nortier J. W. R., Putter H., Kranenbarg E. M., Kroep J. R., Linn S. C. & van de Velde C. J. H. (20170417). Specific adverse events are associated with response to exemestane therapy in postmenopausal breast cancer patients: Results from the TEAMIIA study (BOOG2006-04). : European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Chicago

Fontein D B Y, Charehbili A, Nortier J W R, Putter H, Kranenbarg E Meershoek-Klein, Kroep J R, Linn S C and van de Velde C J H. 20170417. Specific adverse events are associated with response to exemestane therapy in postmenopausal breast cancer patients: Results from the TEAMIIA study (BOOG2006-04). : European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Harvard

Fontein D. B. Y., Charehbili A., Nortier J. W. R., Putter H., Kranenbarg E. M., Kroep J. R., Linn S. C. and van de Velde C. J. H. (20170417). Specific adverse events are associated with response to exemestane therapy in postmenopausal breast cancer patients: Results from the TEAMIIA study (BOOG2006-04). : European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

MLA

Fontein D B Y, Charehbili A, Nortier J W R, Putter H, Kranenbarg E Meershoek-Klein, Kroep J R, Linn S C and van de Velde C J H. Specific adverse events are associated with response to exemestane therapy in postmenopausal breast cancer patients: Results from the TEAMIIA study (BOOG2006-04). : European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 20170417.